We are live on ! Find out more

537 hedge funds and large institutions have $16B invested in Incyte in 2022 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 207 increasing their positions, 172 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 47

20% more repeat investments, than reductions

Existing positions increased: 207 | Existing positions reduced: 172

1.77% more ownership

Funds ownership: 93.36%95.12% (+1.8%)

1% more funds holding

Funds holding: 533537 (+4)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

2% less capital invested

Capital invested by funds: $16.4B → $16B (-$357M)

34% less call options, than puts

Call options by funds: $30.8M | Put options by funds: $46.8M

Holders
537
Holders Change
+4
Holders Change %
+0.75%
% of All Funds
9.01%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
64
Increased
207
Reduced
172
Closed
47
Calls
$30.8M
Puts
$46.8M
Net Calls
-$16.1M
Net Calls Change
+$5.1M

INCY Hedge Fund Activity: Q2 2022 in Review

537 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q2 2022, worth a combined $16B — down 2.2% from $16.4B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new INCY positions and 47 closed out — a net gain of 17 holders — while 207 added to existing stakes and 172 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $174M. The largest seller was UBS Group, cutting an estimated $180M.

  • 537 institutional investors held Incyte (INCY) as of Q2 2022, up from 533 in Q1 2022.
  • Funds reported $16B of Incyte stock for Q2 2022, down 2.2% quarter-over-quarter.
  • 64 funds opened new Incyte positions in Q2 2022 and 47 closed out, a net change of +17 holders.
  • The largest Incyte buyer in Q2 2022 was First Trust Advisors, an estimated $174M added.
  • The largest Incyte seller in Q2 2022 was UBS Group, an estimated $180M sold.

Based on aggregated 13F filings for Q2 2022.